Learn More
Medchemexpress LLC [1,1'-Biphenyl]-3-propanoic acid, a-amino-2'-chloro-5-(phosphonomethyl)-, (aS)- | 174575-17-8 | 98.8% | 25 MG

Supplier: Medchemexpress LLC 25MGHY13059
SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with a pKi value of 7.7. It has been shown to dose-dependently protect mice against maximal electroshock seizures (MES) upon oral administration, with a rapid onset and long duration of action.
- Potent, competitive NMDA receptor antagonist
- Orally active
- Demonstrated pKi value of 7.7
- Protects against maximal electroshock seizures (MES) in vivo
- Offers rapid onset of action
- Provides long duration of action
- High purity of 98.76%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.